id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
666284,461ff98a-eafd-4dae-b462-72a3322bba02,Q3,KEVIN MCGUINESS PLLC,299811,BARR LABS,2008,third_quarter,CPT,"S.1145, the Patent Reform Act of 2007","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2008-10-15T11:50:14-04:00
666285,461ff98a-eafd-4dae-b462-72a3322bba02,Q3,KEVIN MCGUINESS PLLC,299811,BARR LABS,2008,third_quarter,LBR,"S.316, Preserve Access to Affordable Biologics","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2008-10-15T11:50:14-04:00
666286,461ff98a-eafd-4dae-b462-72a3322bba02,Q3,KEVIN MCGUINESS PLLC,299811,BARR LABS,2008,third_quarter,PHA,"Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics; S.623/H.R. 1032, Access to Life Saving Medicine Act","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2008-10-15T11:50:14-04:00